REQUEST A DEMO
Total
USD $0.00
Search more companies

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Profile Updated: May 17, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Tianjin Zhong Xin Pharmaceutical Group Corporation is engaged in manufacturing medicine and pharmaceutical raw materials. The company offers Chinese patent medicines, Chinese medicinal materials, pharmaceutical raw materials and western medicines, bioengineering drugs and nutritious & health products among others. Tianjin Zhong Xin Pharmaceutical key products are Suxiao Jiuxin Wan used in heart disease treatment; Huoxiang Zhengqi Ruan Jiaonang used for treatments in intestines and stomach diseases; Zilong Jin Pian used for treatment of cancer; Jinq Jiangtang Pian used for treatment of diabetes; Weichang An Wan for curing the deceases such as diarrhea; Biqi Jiaonang used for treatment of rheumatism; a-2b Interferon used in increasing immunity; Gliclazide; and Te Zi She Fu used for diminishing inflammation and other medicines. The company has built up wholesale and retail system in various areas of Tianjin Municipality, with a marketing network extending to more than 30 countries and regions as well as all across China through joint venture with pharmaceutical enterprises such as Glax Smithkline America, Teva Israel, Baxter America and Shinpoong Seoul Korea. Tianjin Zhong Xin Pharmaceutical Group Corporation was incorporated in 1992.

Legal Address
No.17 Baidi Road,Nankai District
Tianjin; Tianjin; Postal Code: 300193

Contact Details: Purchase the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited report to view the information.

Website: http://www.zhongxinp.com

Basic Information
Total Employees:
Purchase the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited report to view the information.
Outstanding Shares:
Purchase the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited report to view the information.
Financial Auditors:
Purchase the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited report to view the information.
Incorporation Date:
December 20, 1992
Key Executives
Purchase this report to view the information.
Chairman/Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Beijing Zhong Xin Yaogu Medical Co., Ltd. (c) (China)
100%
Tianjin Chuyun Co., Ltd.(c) (China)
100%
Tianjin Long Shun Rong Development Co., Ltd. (China)
100%
Company Performance
Financial values in the chart are available after Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
5.13%
Total operating revenue
6.43%
Operating profit (EBIT)
54.08%
Net Profit (Loss) for the Period
17.57%
Total assets
5.45%
Total equity
-5.11%
Operating Profit Margin (ROS)
5.13%
Net Profit Margin
1.54%
Return on Equity (ROE)
2.49%
Debt to Equity Ratio
1.95%
Quick Ratio
-0.6%
Cash Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?